List of Tables
Table 1. Global Flunixin Meglumine Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Flunixin Meglumine Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Flunixin Meglumine Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Flunixin Meglumine Injection Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Flunixin Meglumine Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Flunixin Meglumine Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Flunixin Meglumine Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Flunixin Meglumine Injection Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Flunixin Meglumine Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Flunixin Meglumine Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Flunixin Meglumine Injection, Product Type & Application
Table 12. Global Key Manufacturers of Flunixin Meglumine Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Flunixin Meglumine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flunixin Meglumine Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Flunixin Meglumine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Flunixin Meglumine Injection Sales by Region (2020-2025) & (K Doses)
Table 18. Global Flunixin Meglumine Injection Sales Market Share by Region (2020-2025)
Table 19. Global Flunixin Meglumine Injection Sales by Region (2026-2031) & (K Doses)
Table 20. Global Flunixin Meglumine Injection Sales Market Share by Region (2026-2031)
Table 21. Global Flunixin Meglumine Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Flunixin Meglumine Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Flunixin Meglumine Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Flunixin Meglumine Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Flunixin Meglumine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Flunixin Meglumine Injection Sales by Country (2020-2025) & (K Doses)
Table 27. North America Flunixin Meglumine Injection Sales by Country (2026-2031) & (K Doses)
Table 28. North America Flunixin Meglumine Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Flunixin Meglumine Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Flunixin Meglumine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Flunixin Meglumine Injection Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Flunixin Meglumine Injection Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Flunixin Meglumine Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Flunixin Meglumine Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Flunixin Meglumine Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Flunixin Meglumine Injection Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Flunixin Meglumine Injection Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Flunixin Meglumine Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Flunixin Meglumine Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Flunixin Meglumine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Flunixin Meglumine Injection Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Flunixin Meglumine Injection Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Flunixin Meglumine Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Flunixin Meglumine Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Flunixin Meglumine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Flunixin Meglumine Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Flunixin Meglumine Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Flunixin Meglumine Injection Sales (K Doses) by Type (2020-2025)
Table 51. Global Flunixin Meglumine Injection Sales (K Doses) by Type (2026-2031)
Table 52. Global Flunixin Meglumine Injection Sales Market Share by Type (2020-2025)
Table 53. Global Flunixin Meglumine Injection Sales Market Share by Type (2026-2031)
Table 54. Global Flunixin Meglumine Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Flunixin Meglumine Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Flunixin Meglumine Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Flunixin Meglumine Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Flunixin Meglumine Injection Price (US$/Dose) by Type (2020-2025)
Table 59. Global Flunixin Meglumine Injection Price (US$/Dose) by Type (2026-2031)
Table 60. Global Flunixin Meglumine Injection Sales (K Doses) by Application (2020-2025)
Table 61. Global Flunixin Meglumine Injection Sales (K Doses) by Application (2026-2031)
Table 62. Global Flunixin Meglumine Injection Sales Market Share by Application (2020-2025)
Table 63. Global Flunixin Meglumine Injection Sales Market Share by Application (2026-2031)
Table 64. Global Flunixin Meglumine Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Flunixin Meglumine Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Flunixin Meglumine Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Flunixin Meglumine Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Flunixin Meglumine Injection Price (US$/Dose) by Application (2020-2025)
Table 69. Global Flunixin Meglumine Injection Price (US$/Dose) by Application (2026-2031)
Table 70. Norbrook Company Information
Table 71. Norbrook Description and Business Overview
Table 72. Norbrook Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Norbrook Flunixin Meglumine Injection Product
Table 74. Norbrook Recent Developments/Updates
Table 75. Zoteis Company Information
Table 76. Zoteis Description and Business Overview
Table 77. Zoteis Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Zoteis Flunixin Meglumine Injection Product
Table 79. Zoteis Recent Developments/Updates
Table 80. Merck Animal Health Company Information
Table 81. Merck Animal Health Description and Business Overview
Table 82. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Merck Animal Health Flunixin Meglumine Injection Product
Table 84. Merck Animal Health Recent Developments/Updates
Table 85. Virbac Animal Health India Private Limited Company Information
Table 86. Virbac Animal Health India Private Limited Description and Business Overview
Table 87. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product
Table 89. Virbac Animal Health India Private Limited Recent Developments/Updates
Table 90. MSD Animal Health Company Information
Table 91. MSD Animal Health Description and Business Overview
Table 92. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. MSD Animal Health Flunixin Meglumine Injection Product
Table 94. MSD Animal Health Recent Developments/Updates
Table 95. Bengal Remedies Limited Company Information
Table 96. Bengal Remedies Limited Description and Business Overview
Table 97. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Bengal Remedies Limited Flunixin Meglumine Injection Product
Table 99. Bengal Remedies Limited Recent Developments/Updates
Table 100. Wuhan Huisheng Biological Technology Co., Ltd. Company Information
Table 101. Wuhan Huisheng Biological Technology Co., Ltd. Description and Business Overview
Table 102. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product
Table 104. Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments/Updates
Table 105. Qilu Animal Health Products Co., Ltd. Company Information
Table 106. Qilu Animal Health Products Co., Ltd. Description and Business Overview
Table 107. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product
Table 109. Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
Table 110. Baimukang Animal Pharmaceutical Co., Ltd. Company Information
Table 111. Baimukang Animal Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 114. Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
Table 116. Shandong Zhongmu Veterinary Medicine Co., Ltd. Description and Business Overview
Table 117. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product
Table 119. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments/Updates
Table 120. Hebei New Century Pharmaceutical Co., Ltd. Company Information
Table 121. Hebei New Century Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 124. Hebei New Century Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
Table 126. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Description and Business Overview
Table 127. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 129. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 130. Shandong Lukang Pharmaceutical Co., Ltd. Company Information
Table 131. Shandong Lukang Pharmaceutical Co., Ltd. Description and Business Overview
Table 132. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 134. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Flunixin Meglumine Injection Distributors List
Table 138. Flunixin Meglumine Injection Customers List
Table 139. Flunixin Meglumine Injection Market Trends
Table 140. Flunixin Meglumine Injection Market Drivers
Table 141. Flunixin Meglumine Injection Market Challenges
Table 142. Flunixin Meglumine Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Flunixin Meglumine Injection
Figure 2. Global Flunixin Meglumine Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Flunixin Meglumine Injection Market Share by Type: 2024 & 2031
Figure 4. 10ml/Dose Product Picture
Figure 5. 20ml/ Dose Product Picture
Figure 6. Global Flunixin Meglumine Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Flunixin Meglumine Injection Market Share by Application: 2024 & 2031
Figure 8. Animal muscle pain
Figure 9. Animal febrile disease
Figure 10. Others
Figure 11. Global Flunixin Meglumine Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Flunixin Meglumine Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Flunixin Meglumine Injection Sales (2020-2031) & (K Doses)
Figure 14. Global Flunixin Meglumine Injection Average Price (US$/Dose) & (2020-2031)
Figure 15. Flunixin Meglumine Injection Report Years Considered
Figure 16. Flunixin Meglumine Injection Sales Share by Manufacturers in 2024
Figure 17. Global Flunixin Meglumine Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Flunixin Meglumine Injection Players: Market Share by Revenue in Flunixin Meglumine Injection in 2024
Figure 19. Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Flunixin Meglumine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Flunixin Meglumine Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Flunixin Meglumine Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Flunixin Meglumine Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Flunixin Meglumine Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Flunixin Meglumine Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Flunixin Meglumine Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Flunixin Meglumine Injection Sales Market Share by Country (2020-2031)
Figure 44. Latin America Flunixin Meglumine Injection Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Flunixin Meglumine Injection Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Flunixin Meglumine Injection Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Flunixin Meglumine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Flunixin Meglumine Injection by Type (2020-2031)
Figure 54. Global Revenue Market Share of Flunixin Meglumine Injection by Type (2020-2031)
Figure 55. Global Flunixin Meglumine Injection Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Flunixin Meglumine Injection by Application (2020-2031)
Figure 57. Global Revenue Market Share of Flunixin Meglumine Injection by Application (2020-2031)
Figure 58. Global Flunixin Meglumine Injection Price (US$/Dose) by Application (2020-2031)
Figure 59. Flunixin Meglumine Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
